Combination Antibiotic Drops — a detailed guide to composition, benefits, and use.
Synergistic dual-antibiotic combination of Tobramycin and Moxifloxacin for comprehensive coverage of gram-negative and gram-positive ocular pathogens.
Moxicare-T Eye Drops combine two potent antibiotics with complementary spectra of activity: Tobramycin 0.3% (an aminoglycoside with strong gram-negative coverage) and Moxifloxacin 0.5% (a fourth-generation fluoroquinolone with superior gram-positive activity). This dual antibiotic approach provides broad-spectrum coverage from a single formulation, addressing polymicrobial infections and situations where pathogen identification is pending. The combination targets both cell wall synthesis (Tobramycin) and DNA replication (Moxifloxacin) through distinct mechanisms, reducing the likelihood of resistance emergence during treatment.
| Composition | Tobramycin 0.3% + Moxifloxacin 0.5% |
| Volume | 5 mL per bottle |
| pH Range | 6.8 - 7.4 |
| Osmolality | 280 - 330 mOsm/kg |
| Storage | Store at room temperature (15-30°C). Protect from light. |
| Shelf Life | 24 months from date of manufacture |
| Packaging | 5 mL sterile, preservative-free multi-dose bottle |
| Dosage | 1 drop in the affected eye(s) 2-3 times daily for 7-14 days, or as directed by physician |
Explore the complete product page for packaging, dosing, and enquiry options.
View Moxicare-T Eye Drops Enquire NowDiscover more insights on eye health and ophthalmic care.